Find and Pitch Jounalists, Get Your Story Covered

Tags: urothelial carcinoma sacituzumab govitecan cisplatin sacituzumab enfortumab vedotin

	Profile	Recent Articles on Subject
1	1387865 PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	Seagen and Astellas announce results from EV-302 study - about 1 year ago
2	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	MHRA grants approval for bladder cancer drug erdafitinib - 12 days ago ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study - about 2 months ago
3	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Sequencing in Advanced Urothelial Carcinoma - 17 days ago Early Detection Is Key to Higher Cure Rates in Ovarian Cancer - 11 months ago KEYNOTE-A18 Data Are 'Practice-Changing' for Cervical Cancer - 11 months ago The Treatment Landscape for Cervical Cancer Has Changed - 12 months ago Novel Doublet Highly Effective in Low-Grade Serous Ovarian Cancer - 12 months ago Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancer - 12 months ago Experts' Hopes for the Future of dMMR Uterine Cancer Treatment - 12 months ago Uterine Cancer Trials Made Waves This Year, Experts Say - 12 months ago
4	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Spatial Insights into Targeting Ovarian Cancer with CAR T Cell Therapy - about 2 months ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Grants Fast Track Designation to Potential Treatment for Clear Cell Renal Cell Carcinoma - 4 months ago Pembrolizumab, Chemoradiotherapy Meet Overall Survival Endpoint for Cervical Cancer - 8 months ago Study: Overgrowth of Bladder Nerve Cells Could Cause Recurring UTI Symptoms - 9 months ago FDA Approves Enfortumab Vedotin, Pembrolizumab for Treatment of Urothelial Cancer - 11 months ago FDA Approves Belzutifan for Treatment of Advanced Renal Cell Carcinoma - 11 months ago FDA Grants Priority Review to New Drug Application for Belzutifan for Advanced Renal Cell Carcinoma - about 1 year ago
6	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	First-Line Nivolumab Plus Chemo Approved for Bladder Cancer - 9 months ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - 9 months ago Language Minimizing Adverse Events; HPV and Thyroid Cancer; Ultrasound Bras - 11 months ago FDA Approves Belzutifan for Advanced Renal Cell Carcinoma - 11 months ago Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug - 12 months ago TULSA Effective in Controlling Prostate Cancer Long-Term - 12 months ago First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response - 12 months ago Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer - 12 months ago Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancer - 12 months ago FDA OKs New Option for Advanced ROS1-Positive Lung Cancer - about 1 year ago RAF/MEK and FAK Inhibitor Combo Effective in Low-Grade Serous Ovarian Cancer - about 1 year ago RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC - about 1 year ago Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancer - about 1 year ago Could Cetuximab Maintenance Play a Role in RAS Wild-Type Metastatic CRC? - about 1 year ago
7	Randy Dotinga MedPage Today Indie scribbler, advocate. Board member, @ahcj. San Diego WritingAdvocacy	EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk - 10 months ago
8	Pharmaceutical Executive Editorial Staff Pharmaceutical Executive Pharma Executive Magazine. London & New Jersey PharmaceuticalsHealthcare	ProfoundBio's Rinatabart Sesutecan Granted FDA Fast Track Designation for Ovarian Cancer - 10 months ago Zelix Pharmaceuticals Files BLA for PET Imaging Agent for Renal Cell Carcinoma - 11 months ago FDA Approves Padcev/Keytruda Combo for Locally Advanced, Metastatic Urothelial Cancer - 11 months ago FDA Approves Merck's Welireg for Advanced Renal Cell Carcinoma - 11 months ago FDA Grants Breakthrough Designation to Johnson & Johnson’s Novel Treatment for HR-NMIBC - 12 months ago FDA Grants Priority Review to Bristol Myers Squibb's Opdivo Combination for Urothelial Carcinoma - 12 months ago FDA Grants Priority Review to Keytruda Plus Padcev for Urothelial Carcinoma - 12 months ago
9	Carissa Wong Nature Freelance reporter Nature. She/Her. healthenvironmentnaturetech	The cancer physician who helped to deliver a life-extending treatment - 11 months ago
10	Erin Hunter, Assistant Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	FDA Offers Priority Review to Enfortumab Vedotin-Ejfv, Pembrolizumab Combination for Metastatic Bladder Cancer - 12 months ago Nivolumab Combination Regimen Improved Survival of Patients with Bladder Cancer By A Third Compared to Chemotherapy Alone - about 1 year ago

Journalists covering urothelial carcinoma